Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FCNAV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,357
Award facts
- Contract value 100% obligated
- $11,357.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,357.40 to DMS Pharmaceutical Group Inc. on September 19, 2025, for the supply of Nucala 100 mg/mL auto-injectors, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order carries no set-aside designation and is being performed in Park Ridge, Illinois, where the awardee is headquartered. DMS Pharmaceutical Group Inc., a woman-owned small business and registered pharmaceutical wholesaler, was selected to fulfill this requirement through its existing Indefinite Delivery Contract with the Defense Logistics Agency.
DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valid through November 2026, which enables the issuance of delivery orders for a comprehensive range of pharmaceutical items supporting Department of Defense healthcare facilities worldwide. The company's robust portfolio encompasses branded and generic prescription drugs, biologics, and specialized medications including auto-injectors and oncology treatments. This delivery order for Nucala auto-injectors represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain, distributing prescription medications and pharmacy products directly to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FCNAV?
SPE2DB25FCNAV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FCNAV worth?
The government has obligated $11,357 on SPE2DB25FCNAV.
Is contract SPE2DB25FCNAV an order under another contract?
Yes. SPE2DB25FCNAV is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNAV competed?
The extent of competition for SPE2DB25FCNAV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award